t Bristol Myers Squibb, we are committed to providing innovative, high-quality medicines that strive to address the unmet medical needs of patients with serious diseases. Additionally, Bristol Myers Squibb wishes to advance science through supporting novel, independent research that addresses unmet need surrounding our products and therapeutic areas.
We provide support across all phases of development spanning both interventional and non-interventional research. Independent research may be defined within the industry as Investigator Sponsored Research (ISR), Investigator Initiated Research (IIR), Investigator Sponsored Trials (IST) or Investigator Initiated Trials (IIT). The scientific and academic research community may submit a concept application for Investigator Sponsored Research (ISR) through our portal.
The ISR application process is done through an interactive portal allowing all concepts to come into Bristol Myers Squibb via a simple, user friendly website. The ISR portal provides information required to successfully complete your concept submission and transparently enables you track the concept’s progress through governance review. Through the internal governance process, concepts are periodically reviewed for scientific merit and alignment with our product strategy, among other factors. If the concept is endorsed, you may also use the ISR portal as it is a bi-directional gateway providing you with direct access to the internal Bristol Myers Squibb support team.
Bristol Myers Squibb strives to provide a response to your application within four weeks of submission to the portal. If governance endorses the concept, we expect a well-designed protocol to be submitted within 30 days of endorsement while supporting a rapid contracting process aiming to achieve start-up within 180 days of endorsement. Additional information and requirements can be found within the ISR portal. You may also submit any further Investigator Sponsored Research questions using our Investigator Inquiry Form.
Submission of a concept does not imply nor guarantee endorsement. Any support provided from Bristol Myers Squibb is contingent upon an executed research agreement.
Investigator Sponsored Research Portal
Please Note: At this time, BMS will be prioritizing review of new Investigator Sponsored Research concepts related to the use of BMS medicines (abatacept, ozanimod, fedratinib in particular) in the context of COVID-19. All other concept reviews may be delayed or put on hold until which time the effects of the COVID-19 pandemic have stabilized. We will keep investigators informed of estimated timing for the review of these other submissions. Learn More
Areas of Interest
Bristol Myers Squibb is seeking independent research applications across all indications. Within our Areas of Interest, we may outline specific criteria & therapeutic areas but may not include specific details. Concept applications submitted that best align with our interest will be considered & evaluated.
Our Competitive Research Grant process defines specific criteria that must be met for your application to be considered. The window for submission will close at a pre-defined time point. Concept applications that best align with our posted requirements will be considered, evaluated and compared against all other submissions during the open period prior to final determination of award.
Browse our current research listings and begin the application process.
Bristol Myers Squibb fully supports the principles of enhanced transparency through sharing data from clinical trials on our approved medicines with qualified researchers.